Oligosaccharide System Suitability Mixture C (20 ug)

Oligosaccharide System Suitability Mixture D (20 ug)

Olive Leaf Dry Extract (500 mg)

Olive Oil (5 x 200 mg)

Olmesartan Medoxomil (100 mg)

Olmesartan Medoxomil Related Compound A (20 mg) (1-{[2'-(1H-Tetrazol-5-yl)biphenyl-4-yl]methyl}-4,4-dimethyl-2-propyl-1H-furo[3,4-d]imidazol-6(4H)-one)

Olopatadine Hydrochloride (150 mg)

Olopatadine Related Compound B (35 mg) ((Z)-3-{2-(carboxymethyl)dibenzo[b,e]oxepin-11(6H)-ylidene}-N,N-dimethylpropan-1-amine oxide)

Olopatadine Related Compound C (35 mg) ((11-oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid)

Omeprazole (200 mg)